Delivery Order SPE2DB22D2211-SPE2DB25FRYDB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 units, with a ceiling value of $2,208.90. This is a firm fixed-price delivery order with an ultimate completion date of September 16, 2025, and represents a non-set-aside competitive award. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 with a ceiling value of $11,287.97. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procurement. The contract is set to be completed by August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 units, with a ceiling value of $13,606.22. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively issued. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Modafinil 100 mg tablets in unit dose packages of 30 units, with a contract ceiling value of $2,902.27 and an ultimate completion date of September 29, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Modafinil 100 mg tablets in 30-count packages with a contract value of $1,923.92. This firm fixed-price delivery order, which is due for completion by July 15, 2025, represents a single transaction under AmerisourceBergen's larger pharmaceutical supply agreement with the agency. The award was competitively procured with no set-aside designation and will be performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30, with a contract ceiling value of $12,220.34. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of September 16, 2025. The award was made without a set-aside designation, reflecting open competition among qualified pharmaceutical distributors. AmerisourceBergen's performance of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 at a ceiling value of $2,055.22. This non-set-aside, competitively awarded contract reflects a firm fixed-price delivery order with an ultimate completion date of August 8, 2025. The order is being fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 units, with a ceiling value of $1,125.60. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Modafinil 100 mg tablets (30-count) with a ceiling value of $5,437.41. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 29, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 units, with a ceiling value of $2,175.96 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of May 30, 2025. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FRYDBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Modafinil 100 mg tablets in 30-count units, with a ceiling value of $6,926.27. This is a firm fixed-price delivery order with an ultimate completion date of June 2, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support program enabling AmerisourceBergen to supply medications, vaccines, and medical supplies to military healthcare systems worldwide. The Modafinil order supports the Defense Health Agency's medical supply requirements and reflects AmerisourceBergen's role as a critical vendor in the federal pharmaceutical supply chain, with the company's portfolio encompassing both generic and brand-name drugs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 5/30/25 |